Marital status and survival following bladder cancer
- 1Harvard School of Public Health, Department of Society, Human Development and Health, Boston, Massachusetts, USA
- 2Harvard School of Public Health, Center for Society and Health, Boston, Massachusetts, USA
- 3Dana-Farber Cancer Institute, Boston, Massachusetts, USA
- 4University of California, Los Angeles, California, USA
- 5Health Services Research Program, Cancer Care Ontario and Ontario Institute for Cancer Research, Toronto, Ontario, Canada
- Correspondence to Dr GD Datta, Harvard School of Public Health, 677 Huntington Ave., Kresge Building 7th Floor, Boston, MA 02115; gdatta{at}hsph.harvard.edu
- Accepted 1 March 2009
- Published Online First 24 May 2009
Abstract
Background: Marital status has been implicated as a prognostic factor in bladder cancer survival. However, few studies have explored potential mechanisms through which this might occur.
Methods: The study identified 19 982 bladder cancer patients from the SEER-Medicare database (1992–8) and constructed sex-specific Cox proportional hazard models to assess the relation between marital status and 5-year survival, while sequentially adding covariates to test possible mechanisms.
Results: Multivariable Cox analyses suggest that at every stage, married men had better survival than unmarried men independent of age, race, ecologic socioeconomic status, comorbidities, any or aggressive treatment (assessed separately), and accessing a teaching hospital (hazard ratio (HR) 0.80; 95% confidence interval (CI) 0.74 to 0.87). Among women with stages II–IV bladder cancer, age and the presence of comorbid conditions explained the association between marital status and survival. However, among those diagnosed with stage I bladder cancer, none of the covariates explained the association between marital status and decreased mortality (fully adjusted HR 0.72; 95% CI 0.62 to 0.84).
Conclusion: The lack of evidence of mediation through treatment, overall health, SES, or quality of healthcare institution among married men and women with stage I disease suggests they may be benefiting from something other than these factors, perhaps practical or social support.
Footnotes
-
Funding This project was supported by grants from the National Cancer Institute (CA 91753-02) and the Robert Wood Johnson Foundation. At the time the project was complete Dr G.D. Datta was supported by the W.K. Kellogg Fellowship in Health Disparities and the Alonzo Smythe Yerby Postdoctoral Fellowship.
-
Competing interests None.
-
Ethics approval Harvard School of Public Health.
-
Provenance and Peer review Not commissioned; externally peer reviewed.









